Cite
Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8.
MLA
Ariyoshi, K., et al. “Kaposi’s Sarcoma in the Gambia, West Africa Is Less Frequent in Human Immunodeficiency Virus Type 2 than in Human Immunodeficiency Virus Type 1 Infection despite a High Prevalence of Human Herpesvirus 8.” Journal of Human Virology, vol. 1, no. 3, Mar. 1998, pp. 193–99. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10195242&authtype=sso&custid=ns315887.
APA
Ariyoshi, K., Schim van der Loeff, M., Cook, P., Whitby, D., Corrah, T., Jaffar, S., Cham, F., Sabally, S., O’Donovan, D., Weiss, R. A., Schulz, T. F., & Whittle, H. (1998). Kaposi’s sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. Journal of Human Virology, 1(3), 193–199.
Chicago
Ariyoshi, K, M Schim van der Loeff, P Cook, D Whitby, T Corrah, S Jaffar, F Cham, et al. 1998. “Kaposi’s Sarcoma in the Gambia, West Africa Is Less Frequent in Human Immunodeficiency Virus Type 2 than in Human Immunodeficiency Virus Type 1 Infection despite a High Prevalence of Human Herpesvirus 8.” Journal of Human Virology 1 (3): 193–99. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10195242&authtype=sso&custid=ns315887.